{"name":"TRIANA Biomedicines, Inc.","slug":"triana-biomedicines-inc","ticker":"","exchange":"","domain":"trianabiomedicines.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPM05UVTRfZFJ6a2s5bVFNNlplUlVNNjFvMWZqRDIxc1lUZ1hmWGkzaDlwbjdCYlJCVHVTMFRQS3JWdVRMMzVVTmxqalRzYldWR1lRXzBUX0ZJcXc0WFdXYV93YWdRbVZ1ZW1XNDFyWHZzcVkxaVdvS2tObW4yZHc3LTI1clZrOXpfd0kyY3FxSFp2ZTQ5OEJkUHBXTktWUDdJLW9mbGJlTWljZw?oc=5","date":"2026-01-27","type":"pipeline","source":"The Pharma Letter","summary":"Fortitude aims to fuse molecular glues and ADCs with $13m seed - The Pharma Letter","headline":"Fortitude aims to fuse molecular glues and ADCs with $13m seed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOajhYMHJVR3ZaNTRweW53M0NzX09YNlNOVnlDRi1aNkljaXQycmxETGJMU2dNckxPUGxDY2prcW1uRWo1aXFLSkc4N3p0Zk5VUFczdW4wbjBwdms3YVFkYXlmdDR1UkdIaG5SMDhJUTYweGJYSHMzYlBFNW9pdGRxRjhUNk43Q28zeV9YVlJhcms2WnZlV01wSzhpSEVfT2NJSHc?oc=5","date":"2025-12-04","type":"pipeline","source":"The Pharma Letter","summary":"TRIANA Biomedicines closes $120M Series B funding round - The Pharma Letter","headline":"TRIANA Biomedicines closes $120M Series B funding round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwJBVV95cUxQYXRaQUNNcmJwa2JfMkR3UlN5VWltSVhNcHJhUF90VXlmWk1lTTdYLUVRckUzTjlBM3Y1RFNoSzV4ZGhyNGJ6V1UtV2dGbi1mZzVtQnBTM0FKVi1WMno5X0EtQ3dUazB4c1JHNUlMa0lvMWNMR1FWOUpnR29tZnJrWXhvX0p2eHFPNnVnejY4QmEzNzhFaUNISHRvTmZTN3JJYldtVHRVeHptNGRNT1lLaWtaaUI5eVNkOVdmd1RzU3g2SWhUckFZRTMtTnVfdHJZQUJicEtVcHpidk5mZmowck1CY2N6M1FDYmgtN1pZZXpTV1dXN1J2cG84cThDNnVVZG0wMmlvdw?oc=5","date":"2025-12-03","type":"pipeline","source":"Business Wire","summary":"TRIANA Biomedicines Announces Oversubscribed $120M Series B Financing to Advance its Molecular Glue Degrader Pipeline - Business Wire","headline":"TRIANA Biomedicines Announces Oversubscribed $120M Series B Financing to Advance its Molecular Glue Degrader Pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxONVNFTFVTYUdKM0V5UVVOYWJoRWxfMkJnTmk0VmJOVjRXZ3FYYk9ZdG45MUppdzJZcHVBcThmamFaM2ZLdEtzZ3V5NWVyQUZmUEJmbnJjUkRwN0gxT0xHN0xBaURTZzNUMVFHX1lXMllvb0cxVGRXWTE2cU4yVUt4cVdmdEs2VXRZY1NCc3l6ZWwzYnM0TTBSS2tOOWlsRmhoWE9QMzRNQ1VnRDZKSWRkQ3hUYS1xdw?oc=5","date":"2025-12-03","type":"pipeline","source":"Fierce Biotech","summary":"Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic - Fierce Biotech","headline":"Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQQnN0WkxtT1BjaVpzV0dmUTNtM2Nvbm5VS09HbC1tMUVfaXNPT0QtMG5obFdjbzlxN3hxZ3Z3ckdybnlmZXJCN0tjLXFNM1RjV0Z1ay16WVktc1RHUUV5YnlXOGk5ZzBKUWw5eTZtQWhsZ0tMQThxTEt3NHVZUXJGcjNTOVk1WnJvUDh4bFRRRXJJcDg?oc=5","date":"2025-12-03","type":"pipeline","source":"Axios","summary":"Mega-rounds for Triana, Antithesis, and Verkada - Axios","headline":"Mega-rounds for Triana, Antithesis, and Verkada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNcWtXTVAxWnh1ckV6YlhTd1ZaLW9qUXRWMFktYmE4bFZKMThJdlVPWWtLNU9mbWxVT3Bmd1B4ZnZfMzI0bEVQckJiNF9TVE9PVzJnTndBZWFXdTFubGdBdE03SWxBTmNFT2htc0p1NEc0aU5BS1FvNXZ0RHphN1huVXdqbmx0UlpXVGNBMmU2amJHTWE1cHNhZVhGVzcxMy1aWGc1bk5DU3Buc0lHdmJnWjlZVlpSb3lFTklGQ2d5cEE?oc=5","date":"2025-05-28","type":"pipeline","source":"Clarivate","summary":"Pharma Bets Bigger on Fewer Strategic Assets & Platforms - Clarivate","headline":"Pharma Bets Bigger on Fewer Strategic Assets & Platforms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNWXc3d3NjOU9tNk5SODRlV3Zjc0VuUE9jRnJ3djlOVGw5QXdJekpLVXhpVkw4a0luSEk0Q2FENFVsSzlzZnNIcnZDUUZfYURtQjhPZkhSdl8zNmhVZnF6Ri1NclBoQ2tJb1BWVUotSTdoRlQtMUViVlB5cmRabUQtZWhtdC1GdDh0Vk90Z1F4eGRlUXZzODFwY1ZobHN2U0FMZTFrRkxMQ3dITEFrQ01r?oc=5","date":"2024-10-15","type":"deal","source":"Genetic Engineering and Biotechnology News","summary":"Pfizer, Triana Launch Up-to-$1.5B+ Molecular Glue Collaboration - Genetic Engineering and Biotechnology News","headline":"Pfizer, Triana Launch Up-to-$1.5B+ Molecular Glue Collaboration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNWEl4YlhKT2x1cG5PVDR0Y1FpSlRUY05oeGk4WkpnNHdHb2RNWjQ4Nk9BeVZMVXNXUDl1U003SElSMGg0RktLZE11ZXltSHBsRTNHRmRhYTNkUXJGcFBiVU5PTm5aanVJd1NDTmlIeWxrSzlqRE56OURCcm1WNjkwZUlVS050dHdFbDBUaG0ydmo2UDFkSEQwVVRhd1pNa245ck9ETXZ3LXRDZ0hId1ZqSlMxb1d3X2w3WVE?oc=5","date":"2024-10-15","type":"deal","source":"Fierce Biotech","summary":"Pfizer taps Triana to discover molecular glues for cancer and beyond in deal potentially worth $1.5B - Fierce Biotech","headline":"Pfizer taps Triana to discover molecular glues for cancer and beyond in deal potentially worth $1.5B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxObFh4ZGc3TkxhWW04YUxBd2QxWU5icUdPd3llOGdwanZzaEtiendmX3lYeWtleXVXRVE5T1hzVUk5WWhQa1ZzdlFMVUVQb0RRUGZ6SjBBSy10OGFhVm84SUtJQXZTTW1KdWk4RHNyc1ppRWJja3lqUEVPZUNOMUtndWd4T1llNW9sUzFES0hlQUJtQW9TZ0MyWnlzTFBSNEx1Znd5cnZuNlFEQjJ5UXJ2ZTVtNDFhdEx5WVZ3MnJLMkVfTENRVzMzeTBZNUJsamdqNmtlSi1YdHZfeHpBeFVn?oc=5","date":"2022-04-06","type":"pipeline","source":"Business Wire","summary":"TRIANA Biomedicines Launches With $110M to Unlock the Full Potential of Molecular Glues - Business Wire","headline":"TRIANA Biomedicines Launches With $110M to Unlock the Full Potential of Molecular Glues","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}